Denise L Devine bought $14k of SLQT
director at SelectQuote, Inc.. 4,000 shares at an average of $3.62, traded Mar 14, 2025, filed Mar 19, 2025.
Score components
- +15RoleDirector
- 0Trade size$14k at market
- 0Relative to holdingsHoldings up 1.3%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.2%, 3m -37.7%, 6m -43.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001794783-25-000038, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 14, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +4,000 | $3.62 | $14k | 318,583 | Mar 19, 2025 |
Related signals
Other insiders at SelectQuote, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | SelectQuote, Inc. | Denise L Devine director | $4,080 4,000 shares | -1% | |
| 58Moderate | SLQTbuy SelectQuote, Inc. | Robert Clay Grant PRESIDENT | $105k 118,901 shares | +194% | |
| 13Weak | SelectQuote, Inc. | Sarah Taylor Anderson (See Remarks) | $272k 50,000 shares | -98% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.